Fall River, Massachusetts — According to state and local development sources, Cipla USA Inc. plans to build out 83,000 square feet of new space in Fall River. The company plans to occupy the new space at Innovation Way in Fall River, on or about April 1, 2026. According to the company website Cipla USA, the wholly owned subsidiary of Cipla (established in 1935), has been enabling patient access to affordable and high-quality medicines in the US for over 30 years. The company brings a wealth of pharmaceutical experience to the US and provides innovative generic products and advanced drug delivery systems that offer meaningful healthcare solutions to patients in the country. As a pioneer in inhalation therapy/respiratory care, Cipla ranks no. 2 in inhaler sales globally and ranks in the top 3 for US generic respiratory sales. Cipla has invested more than $1 billion dollars in the US with offices and manufacturing plants located in Warren, NJ; Hauppauge, LI; and Fall River, MA, employing nearly 800 people. Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets. Our strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments are well-known. Our 46 manufacturing sites around the world produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 74+ markets.

To learn more about Cipla USA Inc., visit http://www.ciplausa.com/

Company Contact:
Marc Falkin, Chief Executive Officer North America
844-247-5287

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.